INVO Bioscience (NASDAQ:INVO) Shares Down 7%

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) were down 7% during mid-day trading on Monday . The company traded as low as $0.85 and last traded at $0.86. Approximately 212,866 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 2,794,062 shares. The stock had previously closed at $0.92.

INVO Bioscience Price Performance

The company has a current ratio of 0.15, a quick ratio of 0.12 and a debt-to-equity ratio of 2.94. The firm has a market capitalization of $2.36 million, a price-to-earnings ratio of -0.07 and a beta of 1.48. The company’s 50 day moving average is $1.07 and its 200-day moving average is $1.20.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in INVO Bioscience stock. Sabby Management LLC bought a new stake in INVO Bioscience, Inc. (NASDAQ:INVO) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 231,023 shares of the company’s stock, valued at approximately $183,000. INVO Bioscience comprises 0.1% of Sabby Management LLC’s investment portfolio, making the stock its 29th biggest position. Sabby Management LLC owned about 9.43% of INVO Bioscience as of its most recent SEC filing. 12.02% of the stock is currently owned by institutional investors and hedge funds.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.